North American Respiratory Device Market Trends, Growth, Analysis, Segmentation, Industry Outlook and Forecast 2019 - 2025

The North American respiratory device market was valued at around $6.6 billion in 2018 and is estimated to grow at a CAGR of around 6.2% during the forecast period. The rising prevalence of chronic respiratory diseases, increasing geriatric population, and technological advancement are the major factors that augmenting the growth of respiratory device market in North America. The increasing demand from COPD, Sleep Apnea and asthma patients in the US for the respiratory device and favorable reimbursement in the US is favoring the growth of the regional market. North American respiratory device is further analyzed into the US and Canada. The US is the major market due to greater healthcare expenditure and a higher prevalence rate of respiratory diseases. The US respiratory device market was around $6.2 billion in 2018 and is anticipated to grow at a CAGR of around 6.3% during the forecast period.

Get Sample Copy of North American Respiratory Device Market at: https://www.omrglobal.com/request-sample/north-american-respiratory-device-market

Some of the key players of the market include ResMed Corp., Invacare Corp., GlaxoSmithKline PLC, 3M Co., Novartis AG, Omron Healthcare Inc., and others.

The North American respiratory device market is segmented on the basis of product and end-user. The respiratory product segment is further sub-segmented into therapeutic devices, diagnosis and monitoring devices, and consumables and accessories. The therapeutic devices segment is estimated to dominate the regional market and is also anticipated to grow at the fastest growth rate over the forecast period. The high cost of therapeutics device and significant demand for continuous positive airway pressure (CPAP) devices and masks, ventilator, oxygen concentrator, and oxygen hoods contribute majorly to the segmental growth of the market for therapeutic devices. Based on end-user, the market is analyzed into hospitals and clinics, and home care.

For More Information, get A full report of North American Respiratory Device Market is available at: https://www.omrglobal.com/industry-reports/north-american-respiratory-device-market

Additionally, the market is characterized by the presence of several players that are providing respiratory devices within and outside the region. The market players are adopting the strategy of merger & acquisition, product launch and expansion of their manufacturing facilities to increase their market share. For instance, in May 2018, Philips Healthcare acquired Night Balance for expanding its sleep & respiratory care portfolio. The acquisition enables Philips Healthcare to expand its position in the home care market. Further, in January 2018, ResMed introduced Mobi which is a portable oxygen concentrator (POC). Furthermore, in May 2017 Resmed launched Air Touch F20 full face mask with UltraSoft memory for comfortable therapy of the patients. Such advancement in respiratory devices will create enormous opportunities for the market across the globe.

North American Respiratory Device Market Segmentation

North American Respiratory Device Market by Product

o Therapeutic Devices
o Diagnostic and Monitoring Devices
o Consumable and Accessories

North American Respiratory Device Market by End-User

o Homecare
o Hospitals and Clinics

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/north-american-respiratory-device-market

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

This release was published on openPR.